Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Integra Lifesciences 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 USA

P: 609-275-0500 F: 609-750-4277

Description:

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons.

Key Statistics

Overview:

Market Capitalization, $K 4,712,311
Shares Outstanding, K 85,229
Annual Sales, $ 1,472 M
Annual Net Income, $ 60,800 K
Last Quarter Sales, $ 383,320 K
Last Quarter Net Income, $ 25,140 K
60-Month Beta 0.96
% of Insider Shareholders 5.10%
% of Institutional Shareholders 83.05%
Float, K 80,882
% Float 94.90%

Growth:

1-Year Return -0.83%
3-Year Return 71.79%
5-Year Return 144.65%
5-Year Revenue Growth 76.08%
5-Year Earnings Growth 96.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.65 on 02/21/19
Next Earnings Date 04/24/19
Earnings Per Share ttm 2.42
EPS Growth vs. Prev Qtr 10.17%
EPS Growth vs. Prev Year 1.56%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 01/04/17

IART Ratios

Ratio
Price/Earnings ttm 23.69
Price/Earnings forward 26.16
Price/Earnings to Growth 1.69
Return-on-Equity (After Tax) 16.02
Return-on-Assets (Before Tax) 6.40
Net Margin % 6.29
Debt/Equity 1.04
Price/Sales 3.32
Price/Cash Flow 15.24
Price/Book 3.55
Book Value/Share 16.15
Interest Coverage -1.89
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar